Clinical Trials Unit
Stanford University School of Medicine's Center for Advanced Dermatologic Investigation is the Dermatology Department's clinical trials unit.
The Center is home to 12-15 ongoing clinical studies, investigating the safety and efficacy of new and currently available drugs and over-the-counter medications. The Center works with Stanford's own panel on medical research, leading pharmaceutical companies,and the Food and Drug Administration to safely and ethically expand the medical field's knowledge of dermatologic treatments. New studies begin regularly, and the Center continues to recruit patients with skin aging, sun damage, skin cancer (including basal cell carcinomas), psoriasis, atopic dermatitis, rosacea, and other dermatologic diseases for ongoing studies.
Skin Aging Studies
We seek to understand the human aging processes as it relates to skin on a fundamental level. To this end, our studies focus on clinical and translational research efforts ranging from: (1) the analysis of gene changes which predispose individuals to exceptionally youthful skin to (2) molecular signatures that may be biomarkers for aging skin to (3) the careful study of new candidate agents which might affect the skin aging process.
Nonmelanoma Skin Cancer
Recent advances in our understanding of basal cell skin cancer biology have enabled the development of cutting edge study drugs which combat tumor growth. We are currently home to a number of clinical trials at the forefront of potential therapy for advanced or metastatic basal cell cancer. In addition, we seek to understand the biology of basal cell skin cancers and to identify molecular predictors for treatment success.
Acne Rosecea
This is a common and frustrating chronic inflammatory condition of the face, usually affecting older individuals. The causes of this complex condition are the subject of much study. Our clinical studies seek to identify new topical or oral medications to improve the symptoms of acne rosacea.
Contact
For more information, please email dermtrials@stanford.edu
Featured Clinical Trials
The Six-Minute Walking Test (6MWT) as a Measure of Functional Impairment in Lumbar Degenerate Disc Disease.
The study determines the reliability and validity of the 6-Minute Walking Test (6MWT) in patients with lumbar degenerative disc disease (DDD).
Stanford is currently accepting patients for this trial.
Eligibility
Inclusion Criteria:
- Patient scheduled for spine surgery with one of the following diagnosis (1) lumbar
disc herniation (LDH), (2) lumbar spinal stenosis lumbar (LSS) or lumbar DDD with or
without instability requiring lumbar fusion (transforaminal lumbar interbody fusion,
posterior lumbar interbody fusion, or extreme lateral interbody fusion)
- Male and Female subjects ≥ 18 years
- Written informed consent
Exclusion Criteria:
- Pregnancy
- Inability to walk (extreme pain or severe neurological deficits)
- Severe Chronic Obstructive Lung Disease (COPD) corresponding to ≥ Gold III
- Severe heart failure corresponding to ≥ New York Heart Association (NYHA) III
- Lung cancer and diffuse parenchymal lung disease
- Other medical reasons interfering with the patient's ability to walk and perform the
6MWT (e.g., osteoarthritis disease of the lower extremities, Parkinson's disease,
heart failure, hip or knee prosthesis etc.)
- Unavailability for follow up and/or inability to complete assessment (planning to
move, no smartphone, etc.).
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
All
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Recruiting
Psoriasis Clinical Trials
The Six-Minute Walking Test (6MWT) as a Measure of Functional Impairment in Lumbar Degenerate Disc Disease.
The study determines the reliability and validity of the 6-Minute Walking Test (6MWT) in patients with lumbar degenerative disc disease (DDD).
Stanford is currently accepting patients for this trial.
Eligibility
Inclusion Criteria:
- Patient scheduled for spine surgery with one of the following diagnosis (1) lumbar
disc herniation (LDH), (2) lumbar spinal stenosis lumbar (LSS) or lumbar DDD with or
without instability requiring lumbar fusion (transforaminal lumbar interbody fusion,
posterior lumbar interbody fusion, or extreme lateral interbody fusion)
- Male and Female subjects ≥ 18 years
- Written informed consent
Exclusion Criteria:
- Pregnancy
- Inability to walk (extreme pain or severe neurological deficits)
- Severe Chronic Obstructive Lung Disease (COPD) corresponding to ≥ Gold III
- Severe heart failure corresponding to ≥ New York Heart Association (NYHA) III
- Lung cancer and diffuse parenchymal lung disease
- Other medical reasons interfering with the patient's ability to walk and perform the
6MWT (e.g., osteoarthritis disease of the lower extremities, Parkinson's disease,
heart failure, hip or knee prosthesis etc.)
- Unavailability for follow up and/or inability to complete assessment (planning to
move, no smartphone, etc.).
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
All
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Recruiting
Dermatology Clinical Trials
The Six-Minute Walking Test (6MWT) as a Measure of Functional Impairment in Lumbar Degenerate Disc Disease.
The study determines the reliability and validity of the 6-Minute Walking Test (6MWT) in patients with lumbar degenerative disc disease (DDD).
Stanford is currently accepting patients for this trial.
Eligibility
Inclusion Criteria:
- Patient scheduled for spine surgery with one of the following diagnosis (1) lumbar
disc herniation (LDH), (2) lumbar spinal stenosis lumbar (LSS) or lumbar DDD with or
without instability requiring lumbar fusion (transforaminal lumbar interbody fusion,
posterior lumbar interbody fusion, or extreme lateral interbody fusion)
- Male and Female subjects ≥ 18 years
- Written informed consent
Exclusion Criteria:
- Pregnancy
- Inability to walk (extreme pain or severe neurological deficits)
- Severe Chronic Obstructive Lung Disease (COPD) corresponding to ≥ Gold III
- Severe heart failure corresponding to ≥ New York Heart Association (NYHA) III
- Lung cancer and diffuse parenchymal lung disease
- Other medical reasons interfering with the patient's ability to walk and perform the
6MWT (e.g., osteoarthritis disease of the lower extremities, Parkinson's disease,
heart failure, hip or knee prosthesis etc.)
- Unavailability for follow up and/or inability to complete assessment (planning to
move, no smartphone, etc.).
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
All
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Recruiting
Pediatric Dermatology Clinical Trials
The Six-Minute Walking Test (6MWT) as a Measure of Functional Impairment in Lumbar Degenerate Disc Disease.
The study determines the reliability and validity of the 6-Minute Walking Test (6MWT) in patients with lumbar degenerative disc disease (DDD).
Stanford is currently accepting patients for this trial.
Eligibility
Inclusion Criteria:
- Patient scheduled for spine surgery with one of the following diagnosis (1) lumbar
disc herniation (LDH), (2) lumbar spinal stenosis lumbar (LSS) or lumbar DDD with or
without instability requiring lumbar fusion (transforaminal lumbar interbody fusion,
posterior lumbar interbody fusion, or extreme lateral interbody fusion)
- Male and Female subjects ≥ 18 years
- Written informed consent
Exclusion Criteria:
- Pregnancy
- Inability to walk (extreme pain or severe neurological deficits)
- Severe Chronic Obstructive Lung Disease (COPD) corresponding to ≥ Gold III
- Severe heart failure corresponding to ≥ New York Heart Association (NYHA) III
- Lung cancer and diffuse parenchymal lung disease
- Other medical reasons interfering with the patient's ability to walk and perform the
6MWT (e.g., osteoarthritis disease of the lower extremities, Parkinson's disease,
heart failure, hip or knee prosthesis etc.)
- Unavailability for follow up and/or inability to complete assessment (planning to
move, no smartphone, etc.).
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
All
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Recruiting
The Six-Minute Walking Test (6MWT) as a Measure of Functional Impairment in Lumbar Degenerate Disc Disease.
The study determines the reliability and validity of the 6-Minute Walking Test (6MWT) in patients with lumbar degenerative disc disease (DDD).
Stanford is currently accepting patients for this trial.
Eligibility
Inclusion Criteria:
- Patient scheduled for spine surgery with one of the following diagnosis (1) lumbar
disc herniation (LDH), (2) lumbar spinal stenosis lumbar (LSS) or lumbar DDD with or
without instability requiring lumbar fusion (transforaminal lumbar interbody fusion,
posterior lumbar interbody fusion, or extreme lateral interbody fusion)
- Male and Female subjects ≥ 18 years
- Written informed consent
Exclusion Criteria:
- Pregnancy
- Inability to walk (extreme pain or severe neurological deficits)
- Severe Chronic Obstructive Lung Disease (COPD) corresponding to ≥ Gold III
- Severe heart failure corresponding to ≥ New York Heart Association (NYHA) III
- Lung cancer and diffuse parenchymal lung disease
- Other medical reasons interfering with the patient's ability to walk and perform the
6MWT (e.g., osteoarthritis disease of the lower extremities, Parkinson's disease,
heart failure, hip or knee prosthesis etc.)
- Unavailability for follow up and/or inability to complete assessment (planning to
move, no smartphone, etc.).
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
All
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Recruiting
The Six-Minute Walking Test (6MWT) as a Measure of Functional Impairment in Lumbar Degenerate Disc Disease.
The study determines the reliability and validity of the 6-Minute Walking Test (6MWT) in patients with lumbar degenerative disc disease (DDD).
Stanford is currently accepting patients for this trial.
Eligibility
Inclusion Criteria:
- Patient scheduled for spine surgery with one of the following diagnosis (1) lumbar
disc herniation (LDH), (2) lumbar spinal stenosis lumbar (LSS) or lumbar DDD with or
without instability requiring lumbar fusion (transforaminal lumbar interbody fusion,
posterior lumbar interbody fusion, or extreme lateral interbody fusion)
- Male and Female subjects ≥ 18 years
- Written informed consent
Exclusion Criteria:
- Pregnancy
- Inability to walk (extreme pain or severe neurological deficits)
- Severe Chronic Obstructive Lung Disease (COPD) corresponding to ≥ Gold III
- Severe heart failure corresponding to ≥ New York Heart Association (NYHA) III
- Lung cancer and diffuse parenchymal lung disease
- Other medical reasons interfering with the patient's ability to walk and perform the
6MWT (e.g., osteoarthritis disease of the lower extremities, Parkinson's disease,
heart failure, hip or knee prosthesis etc.)
- Unavailability for follow up and/or inability to complete assessment (planning to
move, no smartphone, etc.).
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
All
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Recruiting